PD-L1 Targeting Nanotheranostic for Effective Photoacoustic Imaging Guided Photothermal-Immunotherapy of Tumor
Ruimin Chang,Tan Li,Yao Fu,Zeyu Chen,Yilang He,Xin Sun,Yiyi Deng,Yanqing Zhong,Zuozhong Xie,Yang Yang,Jing Liu,Xiang Chen,Hong Liu,Yuetao Zhao,yanqing zhong
DOI: https://doi.org/10.1039/d3tb00221g
IF: 7.571
2023-08-11
Journal of Materials Chemistry B
Abstract:Tumor immunotherapy has partly been effective for specific cancers. However, it still faces challenges such as low immune response, restricted antitumor efficacy, and high cost of antibodies. Synergistic therapeutic strategies, such as combining immune checkpoint blockade with photothermal therapy and photoacoustic imaging, are expected to provide approaches for more precise and efficient immunotherapy of tumor. Furthermore, developing alternatives for antibodies, such as PD-L1 aptamer and nanocarrier, would reduce the cost of tumor immunotherapy. We develop a PD-L1-targeting nanotheranostic to block immune checkpoint for synergistic photothermal-immunotherapy against tumor, along with effective photoacoustic (PA) imaging in the near-infrared (NIR) window. The nanotheranostic is prepared by modification of gold nanorods (GNR) with PD-L1 aptamer (APDL1), which can sensitively and specifically recognize PD-L1 on tumor cell surface, and mediate nanoparticle accumulation and strong PA signal in tumor. Aptamer is released from GNR by competition of glutathione (GSH) and functionalized as PD-L1 blockade. In collaboration with the concurrent photothermal therapy, antitumor immunity is significantly augmented by enhancing matured dendritic cells filtration and suppressing regulatory T cells, followed by activation of cytotoxic T cells and inhibition of T cell exhaustion. Such a nanotheranostic modality greatly suppress tumor growth on mice, representing an appealing platform for both biological imaging and photoimmunotherapy of tumor.
materials science, biomaterials